Investing · Page 39

Metals One Converts US$1.8M Loan into 30% Stake in South African Gold Plant Valued at US$39.6M

Metals One converts a $1.8M loan into a 30% stake in a South African cogeneration plant valued at $39.6M, gaining exposure to power, steam, and gold roasting revenue streams.

Crystal Amber Fund Proposes Management Overhaul and New Investment Strategy

Insight into Crystal Amber's strategic reset: new management, focused on Morphic Medical, with pivotal EGM vote ahead.

Digitalbox plc Reports 2025 Results: Revenue Up 7% but Cash Generation Plummets

Digitalbox's 2025: 7% revenue growth offset by plunging cash flow. Explore the strategic moves and 2026 outlook here.

Rainbow Rare Earths Interim Results Showcase Robust Economics and Rising REE Prices

Rainbow Rare Earths' interim results reveal a successful pilot plant, rising REE prices, and two high-value projects moving from concept to execution.

Bioventix Interim Results Show Five-Fold Jump in Alzheimer's Antibody Royalties

Bioventix's Alzheimer's antibody royalties surge five-fold, while its core business and dividend remain steady. A story of future potential built on solid foundations.

RTW Biotech Opportunities Reports Strong 2025 Results with NAV Growth and FTSE 250 Inclusion

RTW Biotech Opportunities' 2025: NAV up 35.7%, discount narrows to 12%, and FTSE 250 inclusion boosts visibility. A strong rebound year.

Aberdeen Asia Focus Reports Strong Half-Year Results Driven by AI and Electronics Exposure

Big Technologies Reports 12% ARR Growth Amid Litigation Settlement and US Expansion Drive

Big Technologies reports 12% ARR growth, US expansion momentum, and a major litigation settlement in its 2025 results.

Impax Environmental Markets PLC Forced into Exit Tender Offer After Clash with Activist Shareholder Saba Capital

Gaming Realms Reports Record 2025 Results with 10% Revenue and 15% EBITDA Growth

Gaming Realms posts record 2025 revenue, 15% EBITDA growth & a 48% margin. Cash hits £17.8m with another share buyback announced. A year of solid scaling.

Fusion Antibodies Seals £250k IP Deal, Supporting Finn Therapeutics' Fundraising

Fusion Antibodies sells IP for a £250k year-end revenue boost, supporting client Finn Therapeutics' fundraising in tough biotech markets.

PipeHawk PLC Reports 45% Turnover Drop and Subsidiary Insolvency in H1 2026

PipeHawk's H1 FY26 reports a 45% revenue crash, a swing to loss, and the insolvency of subsidiary Adien. The path forward hinges on a crucial asset sale and key orders.

Corcel Completes Major Angola Seismic Campaign, Eyes Drilling as Balance Sheet Strengthens

Corcel completes largest Angola seismic campaign in 15 years, cash position strengthens ahead of key drilling phase.

Genedrive Posts H1 Results with £4.9m Fundraise, Advances NHS and International Commercialisation

Genedrive secures £4.9m funding, eliminates debt, and gains NHS traction for rapid genetic tests, advancing US and international commercialisation.

Jarvis Securities Reports Interim Results Amid Wind-Down, Plans AIM Delisting

Jarvis Securities interim results show profit from client book sale, but wind-down is key with AIM delisting and capital return ahead.

Mirriad Q1 2026 Trading Update: Sales Impacted by Geopolitical Conflict, New UK Media Deal Secured

Mirriad's Q1 2026: Sales slowed by Iran conflict, but a new UK media deal brings hope. Cash tight, funding needed.

VietNam Holding Reports 10.8% NAV Rise in Interim Update Amid Vietnam's Economic Strength

VietNam Holding reports 10.8% NAV increase as discount narrows to 5.9%, driven by Vietnam's economic strength and strategic stock picks.

Technology Minerals Posts Full Year Results as Recyclus Hits Key Milestones and Expands UK Battery Recycling Footprint

FY25 results: Revenue soars but losses deepen for Technology Minerals. Recyclus shines with battery recycling wins, yet funding remains key challenge.

CPH2 Announces Siemens Collaboration and Key Commercial Milestones in Hydrogen Market

CPH2 announces Siemens collaboration & four firm hydrogen unit orders, with first revenues targeted for Q3 2026 after final Site Acceptance Test.

Team PLC Acquires £157m AUM and Guernsey Platform in Strategic Dual Deal

Team PLC expands via two strategic, share-funded acquisitions: adding £157m in institutional AUM and a Guernsey fiduciary platform for enhanced scale and recurring revenue.

Boohoo Group Reports Strong FY26 EBITDA Growth and Raises FY27 Guidance

Boohoo reports punchy 36% EBITDA growth in its turnaround, raising FY27 guidance.

Spectra Systems Reports 30.7% Revenue Growth and Record Profitability in 2025 Audited Results

Spectra Systems posts 30.7% revenue growth and record 2025 profits, driven by its central bank sensor programme, with a bigger dividend for shareholders.

AOTI Reports 14% Revenue Growth in 2025 Amid US Healthcare Headwinds, Cuts Arizona Medicaid Services

AOTI grew revenue 14% in 2025 but is cutting Arizona Medicaid services due to slow payments. A pivotal US Medicare decision remains the key catalyst for investors.

HICL Infrastructure Acquires Additional 6.65% Stake in Cross London Trains for £52m, Boosting NAV and Governance

HICL Infrastructure's smart £52m stake hike in Cross London Trains drives NAV uplift and stronger governance – a win for shareholders.

Artisanal Spirits Posts FY25 Loss on US Disruption, Unveils Strategic Route-to-Market Shift

Artisanal Spirits' FY25 loss driven by US disruption, with a strategic route-to-market shift aiming for better control and future profit growth.

Accesso Technology Group Acquires Dexibit to Embed AI Across Attractions Sector

Accesso acquires Dexibit, embedding AI to unify attraction data into a predictive intelligence layer, shifting from transactions to insights.

Gunsynd PLC Reports Profit Turnaround and High-Grade Gold Progress in Interim Results

Discover how Gunsynd PLC turned a profit, boosted cash, and advanced high-grade gold projects in their latest interim report.

Absa Group Releases Audited Full-Year 2025 Financial Results

Absa Group's audited FY2025 results are officially published. This RNS is a formal notice - the key financials, capital ratios and dividend details are in the linked PDFs, not the announcement.

Seed Capital Solutions PLC Updates on AI Diagnostics Acquisition and Planned Move to AIM

Seed Capital Solutions updates on AI diagnostics acquisition and AIM move, with audit progress targeting completion by end-April 2026.

Air China Posts Widened Net Loss for 2025 as Costs Outpace Revenue Growth

Revenue rises but losses deepen as passenger yield pressure bites. Air China’s 2025 results show cost growth outpacing revenue, despite international recovery.